Diagnostic timing in cerebral creatine deficiency syndromes: neurodevelopmental and genetic characterization of a multicenter cohort
European Journal of Pediatrics · 2026
DOI: 10.1007/s00431-026-07519-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Pediatrics, 2026. Verfasst von Mehmet Akif Kilic und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Street, Fat…. Hauptthemen laut MEDLINE: Amidinotransferases, Creatine, Guanidinoacetate N-Methyltransferase, Intellectual Disability. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Purpose
Cerebral creatine deficiency syndromes (CCDS) are rare inherited neurometabolic disorders comprising two creatine biosynthesis defects—guanidinoacetate methyltransferase (GAMT) and arginine:glycine amidinotransferase (AGAT) deficiencies—and creatine transporter (CRTR) deficiency. Because early diagnosis and presymptomatic treatment are critical, particularly in biosynthesis defects, this study aimed to delineate the clinical features, diagnostic timing, and genetic spectrum of CCDS, and to describe the outcomes of presymptomatically treated patients.
Methods
This was a retrospective, multicenter cohort study. Clinical, radiological, biochemical, and genetic data were reviewed, and all variants were classified according to the gene-specific ClinGen CCDS Variant Curation Expert Panel specifications. Patients with pathogenic or likely pathogenic variants were considered genetically confirmed; patients whose variants remained of uncertain significance (VUS) were described separately and excluded from comparative analyses.
Results
Of the 22 enrolled patients, 19 were genetically confirmed. Three presymptomatically treated patients with GAMT deficiency remained asymptomatic. Among the 16 symptomatic, genetically confirmed patients, the median diagnostic interval was 88.5 months (IQR 114; range 10–228). All symptomatic patients had global developmental delay or intellectual disability. Four novel variants were identified: the homozygous p.(Arg189His) variant (AGAT deficiency) was classified as likely pathogenic and the homozygous deletion c.242_327+63del (GAMT deficiency) as pathogenic; two hemizygous variants (CRTR deficiency), p.(Trp55Arg) and p.(Gly253Glu), remained VUS.
Conclusion
Favorable neurodevelopmental outcomes in patients with GAMT deficiency treated before symptom onset underscore the importance of clinical awareness and timely diagnosis, and support the rationale for newborn screening. The two novel disease-causing variants expand the genetic spectrum of CCDS. What is Known: • Cerebral creatine deficiency syndromes are rare inherited neurometabolic disorders comprising AGAT, GAMT, and CRTR deficiencies. • Presymptomatic treatment of GAMT deficiency can prevent irreversible neurodevelopmental sequelae. What is New: • Two novel disease-causing variants (likely pathogenic in AGAT deficiency; pathogenic in GAMT deficiency) expand the genetic spectrum; two novel SLC6A8 variants remain of uncertain significance under ClinGen CCDS Expert Panel criteria. • Favorable outcomes in three presymptomatically treated patients with GAMT deficiency support the rationale for newborn screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Neurology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Turgut Ozal Millet Street, Fatih, 34093, Istanbul, Turkey. mehmetakifkilic1@istanbul.edu.tr.
- Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Department of Pediatric Neurology, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey.
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
- Department of Pediatrics and Child Neurology, Faculty of Medicine, Yuksek Ihtisas University, Ankara, Turkey.
- Division of Metabolic Diseases and Nutrition, Department of Pediatrics, Faculty of Medicine, Başkent University, Ankara, Turkey.
Zitieren
APA
Kilic, M. A., Karaman, V., Gencpinar, P., Sakarya Gunes, A., Sonmez, F. M., Aydin, H. I., Bildik, O., Sager, S. G., Aksu Uzunhan, T., Gunay, C., Ates Yaman, O., Ercelebi, H., Basarir, G., Gok, A., Ersoy, M., Sunnetci Akkoyunlu, D., Polat, H., Turkyilmaz, A., Turan, B., …, & Maras Genc, H. (2026). Diagnostic timing in cerebral creatine deficiency syndromes: neurodevelopmental and genetic characterization of a multicenter cohort. European Journal of Pediatrics. https://doi.org/10.1007/s00431-026-07519-9
Vancouver
Kilic MA, Karaman V, Gencpinar P, Sakarya Gunes A, Sonmez FM, Aydin HI, et al. Diagnostic timing in cerebral creatine deficiency syndromes: neurodevelopmental and genetic characterization of a multicenter cohort. European Journal of Pediatrics. 2026. doi:10.1007/s00431-026-07519-9
BibTeX
@article{Kilic2026,
author = {Kilic, Mehmet Akif and Karaman, Volkan and Gencpinar, Pinar and Sakarya Gunes, Ayfer and Sonmez, Fatma Mujgan and Aydin, Halil Ibrahim and Bildik, Olgay and Sager, Safiye Gunes and Aksu Uzunhan, Tugce and Gunay, Cagatay and Ates Yaman, Ozlem and Ercelebi, Hakan and Basarir, Gunce and Gok, Anil and Ersoy, Melike and Sunnetci Akkoyunlu, Deniz and Polat, Hamza and Turkyilmaz, Ayberk and Turan, Betul and Uyanik, Bulent and Agildere, Muhtesem and Kaymakcalan Celebiler, Hande and Mehtar, Muhammed and Olgac Dundar, Nihal and Pembegul Yildiz, Edibe and Kara, Bulent and Maras Genc, Hulya},
title = {Diagnostic timing in cerebral creatine deficiency syndromes: neurodevelopmental and genetic characterization of a multicenter cohort},
journal = {European Journal of Pediatrics},
year = {2026},
doi = {10.1007/s00431-026-07519-9}
}
EUVIMED